Ongoing projects - NANOMED

Project: NANOMED – Nanomedicine for Drug Delivery

Involved UNIPV structure: Dipartimento di Scienze del Farmaco

UNIPV Team: Prof. Carla Caramella, Prof. Bice Conti, Prof. Marco Terreni

Total Budget: € 3.068.000,00

UNIPV Budget: € 141.432,00

Project duration: 15/09/2020 - 15/09/2025

Coordinator: Université Paris Cité - France

Full partners: University of Patras – Greece, University of Pavia – Italy, University of Angers – France

Associated partners:

Galien Institute School of Pharmacy, University of Paris Sud – France, University of Bourgogne – France, University of Nantes – France, ICGM, University of Montpellier – France, University of Turin – Italy, University of Louvain – Belgium, University of Athens – Greece, University of Strasbourg – France, University of Caen – France, University of Tours – France, University of Liège – Belgium, University of Navarra – Spain, University of Granada – Spain, University of Columbia – USA, Foundation for Research and Technology Hellas, Institute of Chemical Engineering Sciences – Greece, (FORTH/ICE-HT) – Greece, CARLINA technologies – France, GATTEFOSSE –Maharashtra-India, GUERBET – Italy, SANOFI – Italy, DEMO PHARMACEUTICALS – Greece, ELPEN – Greece, VERISFIELD – Greece, Proxagen – Bulgaria, The European Technology Platform for Nanomedicine (ETPN) – France, The Society of Drug Delivery Sciences and Technology (APGI) – France, The French Society of Nanomedicine (SF Nano) – France, The Greek Chapter of the Controlled Release Society and the Panhellenic Pharmaceutical Union (PEF) – Greece, the Italian Chapter of the Controlled Release Society (CRS) and the Italian Association of Industrial Pharmacists (AFI), The BeNeLux & France chapter of the Controlled Release Society (CRS) – Italy, Pierre Fabre Fondation – France

Description:

This 23 months, 120 ECTS Master’s Course in English offers a high quality and multidisciplinary education in the emerging field of Nanomedicine. The consortium is composed of four Universities: Paris (Fr, coordinator), Patras (Gr), Pavia (It) and Angers (Fr).

Nanomedicine is a revolutionary interdisciplinary science, combining knowledge from Physics, Biology, Chemistry and Medicine to treat diseases of the human body. The NANOMED consortium has brought together the expertise of four Universities in their respective domains of Nanomedicine. Renowned experts in the field from academia and industry are involved in the pedagogical staff. The final goal is to achieve the qualification of young scientists with appropriate credentials to lead the related field, either in Industry or in Academia. Upon graduation, each student will receive four Master’s degree diplomas corresponding to the National diplomas of the founding Universities.

Regarding the course content, the first semester (S1) taking place in Paris or Patras is dedicated to the “Introduction to pharmaceutical formulation” (Biopharmacy, formulation, production, controls). This first level provides the essential knowledge necessary to work in Pharmaceutical domains and to introduce innovative drug delivery system. Specific courses on chemistry or biology will be proposed to students with a scientific background who are non-pharmacist. At the end of S1, all students will follow practical courses in Paris. The second semester will be dedicated to “Basic Nanomedicine and Biomolecules”. A 3-months traineeship carried out in selected laboratories will conclude S2. The Advanced Nanomedicine part of the curriculum (S3) corresponds to the specialization of students by choosing a training option according to their professional project. In Pavia, S3 will be dedicated to the “Production and Specific Applications of Nanoparticles” providing students with in-depth knowledge on different applications of nanoparticles and production, regulations and quality by design. In Angers, “Strategy of Pharmaceutical Development and Non-Clinical Development of Nanomedicines” is training professionals to manage innovative research projects with skills in Nanomedicine transfer from research to pre-clinical applications. During the final traineeship period (S4, 6 months), students apply this new knowledge to the successful achievement of research and development projects on Nanomedicine carried out in academic or industrial laboratories.

The curriculum will also allow NANOMED participants to attend one summer school and two workshops organized by the consortium.Application requirements will include the completion of a Bachelor’s degree in Pharmacy, or (under special provisions) in Chemistry, Biology, Biochemistry, Material Sciences or other adequate discipline. English language proficiency is also required.